Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06999057 · ClinicalTrials.gov registry record · Early Phase 1
Quadriceps Motor Unit Adaptation to Simulated Knee Injury
A Early Phase 1 study, sponsored by University of Central Florida.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 45
- Enrollment target
NCT06999057 is a Early Phase 1 study that is actively recruiting participants, run by University of Central Florida. The registered enrollment target is 45 participants.
The verdict
NCT06999057, a Early Phase 1 study, is actively recruiting participants, sponsored by University of Central Florida.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 45 participants
- Enrollment target
Study Summary
This study investigates how simulated knee injury-via artificial joint effusion or deafferentation-affects quadriceps motor unit behavior in healthy young adults. Participants will complete neuromuscular testing during a single 2-hour lab session. This research seeks to improve understanding of muscle inhibition and inform interventions after real-world knee trauma.
Interventions
- OTHER Sham injection
- DEVICE Joint Effusion via 60 mL Sterile Saline
- DRUG Intra-articular Lidocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2026-08-01 |
| Est. Completion | 2027-08-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06999057
The ClinicalTrials.gov registry entry for NCT06999057 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Central Florida, which has 91 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Sham injection is the first listed.
NCT06999057 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06999057 about?
NCT06999057 is a clinical study titled "Quadriceps Motor Unit Adaptation to Simulated Knee Injury". This study investigates how simulated knee injury-via artificial joint effusion or deafferentation-affects quadriceps motor unit behavior in healthy young adults. Participants will complete neuromuscular testing during a single 2-hour lab session. This research seeks to improve understanding of musc...
What is the current status of trial NCT06999057?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 45 participants. The study started on 2026-08-01. Estimated completion is 2027-08-01.
What interventions are being tested in trial NCT06999057?
The interventions under investigation include: Sham injection (OTHER), Joint Effusion via 60 mL Sterile Saline (DEVICE), Intra-articular Lidocaine (DRUG).
Who is sponsoring clinical trial NCT06999057?
This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.